Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-15

FDA Approved: PENTAZOCINE AND NALOXONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for the pentazocine and naloxone analgesic product from Sun Pharmaceutical Industries, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pentazocine and Naloxone (Pentazocine hydrochloride and naloxone hydrochloride)

Snippet

SUPPL AP for PENTAZOCINE AND NALOXONE (PENTAZOCINE AND NALOXONE)